What is Relay Therapeutics, Inc.'s investing cash flow?

Relay Therapeutics, Inc. (RLAY) reported investing cash flow of $32.9M in Q1 2026.

How has Relay Therapeutics, Inc.'s investing cash flow changed year-over-year?

Relay Therapeutics, Inc.'s investing cash flow decreased by 22.5% year-over-year, from $42.47M to $32.9M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Relay Therapeutics, Inc. RLAY Investing Cash Flow

Investing Cash Flow at other companies

CelcuityCELC

$34.52M+42.3%

Revolution Medicines, Inc.RVMD

$172.62M+1,182%

Ligand PharmaceuticalsLGND

-$94.35M-2,028%

Cogent Biosciences, Inc.COGT

-$36.46M-153%

Tango TherapeuticsTNGX

$9.64M-68.5%

Spyre Therapeutics, Inc.SYRE

$56.58M+92,856%

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.46B+300%

Enterprise value$3.29B+304%

P/S324.1×+212×

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s investing cash flow?: Relay Therapeutics, Inc. (RLAY) reported investing cash flow of $32.9M in Q1 2026.
How has Relay Therapeutics, Inc.'s investing cash flow changed year-over-year?: Relay Therapeutics, Inc.'s investing cash flow decreased by 22.5% year-over-year, from $42.47M to $32.9M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.